Ad
ATHX - Athersys Stock Trading
About | Athersys Inc. (NASDAQ:ATHX)
Not available
Quote | Athersys Inc. (NASDAQ:ATHX)
| Last: | $0.1018 |
|---|---|
| Change Percent: | -37.41% |
| Open: | $0.1348 |
| Close: | $0.1018 |
| High: | $0.1348 |
| Low: | $0.0982 |
| Volume: | 78,968,068 |
| Last Trade Date Time: | 10/17/2023 03:00:00 am |
News | Athersys Inc. (NASDAQ:ATHX)
-
2023-11-17 06:28:55 ET More on Athersys Athersys crashes after bankruptcy warning Seeking Alpha’s Quant Rating on Athersys Historical earnings data for Athersys Financial information for Athersys For further details see: Athersys GAAP EPS o...
-
Athersys, Inc. (OTC: ATHX), a regenerative medicine company developing MultiStem ® (invimestrocel) cell therapy for critical care indications, announced financial results for the three and nine months ended September 30, 2023 and provided a business update. Third Quarter 2023 and...
Message Board Posts | Athersys Inc. (NASDAQ:ATHX)
| Subject | By | Source | When |
|---|---|---|---|
| Have a look at this | goupupup | investorshub | 05/17/2023 7:08:03 AM |
| is it bear time? Or do we go bull? | RagingStocks | investorshub | 05/15/2023 12:43:50 PM |
| $ATHX is it bear time? Or do we go bull? | longtrailer | investorshub | 05/15/2023 9:09:36 AM |
| MomentumIts now | goupupup | investorshub | 05/13/2023 6:09:30 AM |
| $ATHX Price trading up | goupupup | investorshub | 05/13/2023 2:50:02 AM |
News, Short Squeeze, Breakout and More Instantly...
Ad
-
Athersys, Inc. (OTC: ATHX), a regenerative medicine company developing MultiStem ® (invimestrocel) cell therapy for critical care indications, announced financial results for the three and nine months ended September 30, 2023 and provided a business update. Third Quarter 2023 and...
-
INVO BioScience Inc. (INVO) is expected to report for Q3 2023 HIVE Blockchain Technologies Ltd (HIVE) is expected to report $-0.13 for Q2 2024 BioNexus Gene Lab Corp (BGLC) is expected to report for Q1 2024 Adhera Therapeutics Inc (ATRX) is expected to report for Q1 2024 Altus Pow...
-
Gainers SciSparc Ltd. (NASDAQ: SPRC) shares climbed 146.2% to $6.97. Aegis Capital Corp. acted as exclusive placement agent on a $5.0 million pri...